Subsequent Event (Details) - Roivant Sciences Ltd. (RSL) - Subsequent Event $ / shares in Units, $ in Millions |
Aug. 02, 2021
USD ($)
$ / shares
shares
|
|---|---|
| Subsequent Event [Line Items] | |
| Number of shares issued in transaction (in shares) | shares | 17,021,276 |
| Common stock, par value (in dollars per share) | $ 0.0001 |
| Common stock, sale price (in dollars per share) | $ 11.75 |
| Consideration received from sale of stock | $ | $ 200.0 |
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|